Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003WO2002100420A3 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002087583B1 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002072146A3 Combination of nateglinide or repaglinide with at least one further antidiabetic compound
11/20/2003WO2002069906A3 Compounds and methods for the treatment of urogenital disorders
11/20/2003WO2002067941A3 Combination comprising a signal transduction inhibitor and an epothilone derivative
11/20/2003WO2002066048A8 Crystal modification of a cyclic depsipeptide having improved strength
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002060462A8 Waay to obtain a extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it
11/20/2003WO2002058731A3 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
11/20/2003WO2002056823A8 Redox therapy for tumors
11/20/2003WO2002055081A3 Use of chelators in the treatment of macular degenerative disease
11/20/2003WO2002047691A9 Protection of neurons against glutamate-induced damage in glaucoma and other conditions
11/20/2003WO2002044159A8 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002033050A8 Methods and compositions for promoting the maturation of monocytes
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003WO2002032407A3 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
11/20/2003WO2002028836A9 Novel crystalline forms of a factor xa inhibitor
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030217371 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
11/20/2003US20030216699 Drug delivery; restenosis therapy
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216584 Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent
11/20/2003US20030216576 Methods for preparing CETP inhibitors
11/20/2003US20030216575 Novel pyranosyl cytosines: pharmaceutical formulations and methods
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216568 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216555 Processes for preparing clarithromycin polymorphs
11/20/2003US20030216481 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse
11/20/2003US20030216480 Reducing concentration chaperone protein; Alzheimer's disease; administering methoxychlor
11/20/2003US20030216479 Novel compositions comprising 2,2-Bis (4-hydroxy-3-methylphenyl) heptane and uses thereof
11/20/2003US20030216477 Adrenergic blocking agent
11/20/2003US20030216475 Pharmaceutical composition
11/20/2003US20030216474 Method of using prostacyclin to treat respiratory syncytial virus infections
11/20/2003US20030216472 Moderation of glutamate receptors
11/20/2003US20030216471 Retinoid formulations for aerosolization and inhalation
11/20/2003US20030216470 Method for treating ileus
11/20/2003US20030216469 Cyclic amino acid derivatives useful as pharmaceutical agents
11/20/2003US20030216468 Thiol-based NAALADase inhibitors
11/20/2003US20030216465 Anti-constipation composition
11/20/2003US20030216464 Synergistic mixture of plant extracts
11/20/2003US20030216463 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
11/20/2003US20030216462 Anticancer agents; psoriasis
11/20/2003US20030216461 Mixture of cyclooxygenase inhibitor, non-steroid antiinflammatory drug and acetaminophen; concurrent administering
11/20/2003US20030216460 N3 alkylated benzimidazole derivatives as MEK inhibitors
11/20/2003US20030216459 Small-molecule modulators of hepatocyte growth factor / scatter factor activities
11/20/2003US20030216458 Combination therapy for the treatment of migraine
11/20/2003US20030216457 Method for increasing the bioavailability of metaxalone
11/20/2003US20030216456 Benzoxazole derivatives as novel melatonergic agents
11/20/2003US20030216455 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
11/20/2003US20030216454 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/20/2003US20030216453 Thiazolidine derivatives and its use as antifungal agent
11/20/2003US20030216452 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/20/2003US20030216451 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216449 Phosphate transport inhibitors
11/20/2003US20030216448 Treatment of neuropathic pain
11/20/2003US20030216447 Compositions and method for treating infection in cattle and swine
11/20/2003US20030216446 Aryl ureas as kinase inhibitors
11/20/2003US20030216445 Osteoporosis; immunosuppressants; wound healing agent
11/20/2003US20030216443 Antidiabetic agents; using mixture of enzyme inhibitors
11/20/2003US20030216440 Process for preparing arylacetylaminothiazoles
11/20/2003US20030216439 Therapy for nosal polyps
11/20/2003US20030216438 Antimicrobial agent
11/20/2003US20030216437 Thrombin receptor antagonists
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216433 Gastrointestinal disorders; serotonine receptor antagonist; side effect reduction
11/20/2003US20030216432 Non-insulin sensitive diabetes; anticancer agents ; therapy, medical diagnosis
11/20/2003US20030216431 Antiinflammatory agents; vision defects; antiallergens; topical applying
11/20/2003US20030216430 3, 4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216428 Sexual disorders; blood disorders; osteoporosis; bone disorders
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216426 Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs
11/20/2003US20030216425 Tricyclic compounds as mrp1-inhibitors
11/20/2003US20030216424 Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
11/20/2003US20030216423 Mixture of loratadine and pseudoephedrin sulfate; antiallergens, antiinflammatory agents
11/20/2003US20030216422 Methods for treating multidrug resistance
11/20/2003US20030216421 Cascade esters of camptothecins and methods of treating cancer using these compounds
11/20/2003US20030216420 Pharmaceutical composition for treating fecal incontinence and anal itch
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216418 Novel compositions comprising trimetrexate and methods of their synthesis and use
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216416 Novel crystalline of n-[4-[2-(2-amino-4,7-dihydro-4oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process therefor
11/20/2003US20030216414 Administering a signal transduction compound; phospholipase inhibitor; cystic fibrosis
11/20/2003US20030216413 Catecholamine pharmaceutical compositions and methods
11/20/2003US20030216410 Administering to a cancer patient an indole-2-one derivative containing pyrrole ring as protein kinase inhibitor together with a cyclooxygenase inhibitor to treat the cancer
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216408 -4-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl)-piperazin -1-yl)propy l)-N-pyridin-2-yl-benzamide or salt; useful as 5-HT1A receptor antagonists
11/20/2003US20030216407 Treating the patient with sildenafil for the treatment or prevention of scarring or fibrosis in the tissue
11/20/2003US20030216406 Pyrimidine derivatives
1 ... 5269 5270 5271 5272 5273 5274 5275 5276 5277 5278 5279 5280 5281 5282 5283 5284 5285 5286 5287 5288 5289 ... 7860